» Authors » Monika Pietrowska

Monika Pietrowska

Explore the profile of Monika Pietrowska including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 78
Citations 1244
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Kurczyk A, Gawin M, Paul P, Chmielik E, Rutkowski T, Pietrowska M, et al.
Molecules . 2022 Sep; 27(17). PMID: 36080226
Different aspects of intra-tumor heterogeneity (ITH), which are associated with the development of cancer and its response to treatment, have postulated prognostic value. Here we searched for potential association between...
12.
Zebrowska A, Jelonek K, Mondal S, Gawin M, Mrowiec K, Widlak P, et al.
Cells . 2022 Jun; 11(12). PMID: 35741093
Exosomes that are released by T cells are key messengers involved in immune regulation. However, the molecular profiling of these vesicles, which is necessary for understanding their functions, requires their...
13.
Smolarz M, Skoczylas L, Gawin M, Krzyzowska M, Pietrowska M, Widlak P
Int J Mol Sci . 2022 Apr; 23(8). PMID: 35456987
Exosomes released by irradiated cells mediate the radiation-induced bystander effect, which is manifested by DNA breaks detected in recipient cells; yet, the specific mechanism responsible for the generation of chromosome...
14.
Strybel U, Marczak L, Zeman M, Polanski K, Mielanczyk L, Klymenko O, et al.
Cancers (Basel) . 2022 Feb; 14(4). PMID: 35205741
Identification of biomarkers that could be used for the prediction of the response to neoadjuvant radiotherapy (neo-RT) in locally advanced rectal cancer remains a challenge addressed by different experimental approaches....
15.
Ciardullo C, Szoltysek K, Zhou P, Pietrowska M, Marczak L, Willmore E, et al.
Cancers (Basel) . 2022 Jan; 14(1). PMID: 35008187
Chronic lymphocytic leukaemia (CLL) is a heterogeneous disease with a highly variable clinical outcome. There are well-established CLL prognostic biomarkers that have transformed treatment and improved the understanding of CLL...
16.
Golebiewska J, Wardowska A, Pietrowska M, Wojakowska A, Debska-Slizien A
Cells . 2021 Nov; 10(11). PMID: 34831212
Small extracellular vesicles (sEV), which are released to body fluids (e.g., serum, urine) by all types of human cells, may stimulate or inhibit the innate and adaptive immune response through...
17.
Smolarz M, Kurczyk A, Jelonek K, Zyla J, Mielanczyk L, Sitkiewicz M, et al.
Cancers (Basel) . 2021 Jul; 13(14). PMID: 34298629
Molecular components of exosomes and other classes of small extracellular vesicles (sEV) present in human biofluids are potential biomarkers with possible applicability in the early detection of lung cancer. Here,...
18.
Mrowiec K, Chadalski M, Paszek A, Vydra N, Janus P, Pietrowska M, et al.
Biochim Biophys Acta Mol Cell Res . 2021 Jun; 1868(10):119086. PMID: 34175335
The mouse 3110001I22Rik gene located in the first intron of Bfar is considered as a Bfar variant coding for the BFARv3 protein. However, it differs from other BFAR isoforms and...
19.
Lysek-Gladysinska M, Wieczorek A, Jozwik A, Walaszczyk A, Jelonek K, Szczukiewicz-Markowska G, et al.
Cells . 2021 Mar; 10(3). PMID: 33652838
Biological aging is associated with various morphological and functional changes, yet the mechanisms of these phenomena remain unclear in many tissues and organs. Hyperlipidemia is among the factors putatively involved...
20.
Pietrowska M, Zebrowska A, Gawin M, Marczak L, Sharma P, Mondal S, et al.
J Extracell Vesicles . 2021 Feb; 10(4):e12063. PMID: 33613873
Molecular profiling of small extracellular vesicles (sEV) isolated from plasma of cancer patients emerges as promising strategy for biomarkers discovery. We investigated the proteomic profiles of sEV immunoselected using anti-CSPG4...